Invention Grant
- Patent Title: Safe potent single platform vaccine against Tier 1 select agents and other pathogens
-
Application No.: US16319812Application Date: 2017-07-31
-
Publication No.: US11224647B2Publication Date: 2022-01-18
- Inventor: Marcus A. Horwitz , Qingmei Jia
- Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Agency: Gates & Cooper LLP
- International Application: PCT/US2017/044741 WO 20170731
- International Announcement: WO2018/026729 WO 20180208
- Main IPC: A61K39/114
- IPC: A61K39/114 ; A61P37/04 ; C07K14/32 ; A61K39/02 ; A61K39/07 ; C12N1/36 ; C07K14/195 ; C12N1/20 ; A61K9/00 ; A61K39/04 ; A61K39/235 ; C07K14/20 ; C07K14/36 ; A61K39/00

Abstract:
A method of immunizing a susceptible host against a pathogen comprising administering to the host a vaccine that comprises an attenuated recombinant live vaccine strain lacking a polynucleotide encoding CapB (LVS ΔcapB), wherein the LVS ΔcapB expresses an antigen of at least one pathogen from Table 1; or administering to the host a vaccine that comprises an attenuated Listeria monocytogenes expressing the antigen of the pathogen from Table 1; or administering to the host a prime vaccine and a heterologous booster vaccine where the prime vaccine comprises an attenuated recombinant live vaccine strain lacking a polynucleotide encoding CapB (LVS ΔcapB), wherein the LVS ΔcapB expresses an antigen of at least one pathogen from Table 1 and the heterologous booster vaccine comprises an attenuated Listeria monocytogenes expressing the antigen of the pathogen from Table 1.
Public/Granted literature
- US20190240310A1 SAFE POTENT SINGLE PLATFORM VACCINE AGAINST TIER 1 SELECT AGENTS AND OTHER PATHOGENS Public/Granted day:2019-08-08
Information query